Page last updated: 2024-11-05

thiotepa and Lymphopenia

thiotepa has been researched along with Lymphopenia in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Lymphopenia: Reduction in the number of lymphocytes.

Research Excerpts

ExcerptRelevanceReference
"Lymphopenia was also a significant prognostic factor for progression-free survival (HR 3."1.43A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma. ( Cheong, JW; Cho, H; Chung, H; Jang, JE; Kim, JS; Kim, SJ; Kim, Y; Kim, YR; Lee, JY; Min, YH; Park, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jang, JE1
Kim, YR1
Kim, SJ1
Cho, H1
Chung, H1
Lee, JY1
Park, H1
Kim, Y1
Cheong, JW1
Min, YH1
Kim, JS1

Other Studies

1 other study available for thiotepa and Lymphopenia

ArticleYear
A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 57

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neopla

2016